Crescent My heart is with you and also my position, but I cannot ignore Investor's caution...for a long time I have been thinking approval with a Phase 4 confirmatory trial....he understands the normal way.
My hopes are with the Peer Group endorsement who certainly are more informed than most, but also the OLE data...
This super soft trading seems to suggest that the shorts might be stepping into some mud at this point!
I picked up from that EMA process that at least the change is NOT to have a prolonged scrutiny, that a welcome change to this "process"